Emilie Hybertsen Lysø
Biographic Data
| ID | 257871 |
|---|---|
| NAME | Emilie Hybertsen Lysø |
| GIVEN NAMES | Emilie Hybertsen |
| FAMILY NAME | Lysø |
| SIGNATURE | LYSØ E H |
| AFFILIATIONS | Department of Public Health and Nursing Norwegian University of Science and Technology Trondheim Norway |
| ORCID | 0009-0009-9265-0740 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 3 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2024 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 1 |
Perspectives on prostate cancer screening with PSA – a focus group study with men in Norway aged 54–85 years
Prostate cancer is the second most commonly diagnosed cancer worldwide, leading the European Commission to suggest prostate cancer screening with prostate specific antigen (PSA) as part of their policy for more and better screening. Screening with PSA is, however, contested due to ambiguous evidence of whether benefits outweigh negative consequences. Treatment may cause incontinence and impotence, potentially threatening masculinity. Learning tha…
Men's sociotechnical imaginaries of artificial intelligence for prostate cancer diagnostics - A focus group study
Artificial intelligence (AI) is increasingly used for diagnostic purposes in cancer care. Prostate cancer is one of the most prevalent cancers affecting men worldwide, but current diagnostic approaches have limitations in terms of specificity and sensitivity. Using AI to interpret MR images in prostate cancer diagnostics shows promising results, but raises questions about implementation, user acceptance, trust, and doctor-patient communication. D…
Valuing good health care: How medical doctors, scientists and patients relate ethical challenges with artificial intelligence decision-making support tools in prostate cancer diagnostics to good healt…
Artificial intelligence (AI) is increasingly used in health care to improve diagnostics and treatment. Decision-making tools intended to help professionals in diagnostic processes are developed in a variety of medical fields. Despite the imagined benefits, AI in health care is contested. Scholars point to ethical and social issues related to the development, implementation, and use of AI in diagnostics. Here, we investigate how three relevant gro…
Men's sociotechnical imaginaries of artificial intelligence for prostate cancer diagnostics - A focus group study
Artificial intelligence (AI) is increasingly used for diagnostic purposes in cancer care. Prostate cancer is one of the most prevalent cancers affecting men worldwide, but current diagnostic approaches have limitations in terms of specificity and sensitivity. Using AI to interpret MR images in prostate cancer diagnostics shows promising results, but raises questions about implementation, user acceptance, trust, and doctor-patient communication. D…
Men's sociotechnical imaginaries of artificial intelligence for prostate cancer diagnostics - A focus group study
Artificial intelligence (AI) is increasingly used for diagnostic purposes in cancer care. Prostate cancer is one of the most prevalent cancers affecting men worldwide, but current diagnostic approaches have limitations in terms of specificity and sensitivity. Using AI to interpret MR images in prostate cancer diagnostics shows promising results, but raises questions about implementation, user acceptance, trust, and doctor-patient communication. D…
Valuing good health care: How medical doctors, scientists and patients relate ethical challenges with artificial intelligence decision-making support tools in prostate cancer diagnostics to good healt…
Artificial intelligence (AI) is increasingly used in health care to improve diagnostics and treatment. Decision-making tools intended to help professionals in diagnostic processes are developed in a variety of medical fields. Despite the imagined benefits, AI in health care is contested. Scholars point to ethical and social issues related to the development, implementation, and use of AI in diagnostics. Here, we investigate how three relevant gro…
Perspectives on prostate cancer screening with PSA – a focus group study with men in Norway aged 54–85 years
Prostate cancer is the second most commonly diagnosed cancer worldwide, leading the European Commission to suggest prostate cancer screening with prostate specific antigen (PSA) as part of their policy for more and better screening. Screening with PSA is, however, contested due to ambiguous evidence of whether benefits outweigh negative consequences. Treatment may cause incontinence and impotence, potentially threatening masculinity. Learning tha…
Artificial Intelligence (2 works) · Artificial Intelligence in Healthcare and Education (2 works) · Computer Science (2 works) · Ethics and Social Impacts of AI (2 works) · Ethics in Clinical Research (2 works) · Focus group (2 works) · Medicine (2 works) · Prostate cancer (2 works) · Psychology (2 works) · Sociology (2 works)